AlphaCrest Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-15,100	Closed	-$702K	–	1268
2019 Q2	$702K	Buy	+15,100	New	+$702K	0.06%	559